Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
enCore Energy Corp. stock logo
EU
enCore Energy
$2.98
+0.3%
$2.31
$1.01
$4.44
$557.43M1.861.88 million shs2.09 million shs
Fission Uranium Corp. stock logo
FCU
Fission Uranium
C$0.88
C$0.70
C$1.38
C$618.29M2.692.75 million shs2.54 million shs
IsoPlexis Co. stock logo
ISO
IsoPlexis
$0.76
$0.86
$0.60
$5.10
$30.28M1.3268,375 shsN/A
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
enCore Energy Corp. stock logo
EU
enCore Energy
0.00%+11.19%+22.13%+115.16%-28.37%
Fission Uranium Corp. stock logo
FCU
Fission Uranium
0.00%0.00%0.00%0.00%-43.31%
IsoPlexis Co. stock logo
ISO
IsoPlexis
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
enCore Energy Corp. stock logo
EU
enCore Energy
0.937 of 5 stars
1.82.00.00.03.30.00.6
Fission Uranium Corp. stock logo
FCU
Fission Uranium
N/AN/AN/AN/AN/AN/AN/AN/A
IsoPlexis Co. stock logo
ISO
IsoPlexis
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
enCore Energy Corp. stock logo
EU
enCore Energy
3.50
Strong Buy$2.75-7.72% Downside
Fission Uranium Corp. stock logo
FCU
Fission Uranium
2.50
Moderate BuyC$1.21∞ Upside
IsoPlexis Co. stock logo
ISO
IsoPlexis
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest BKY, ISO, FCU, and EU Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/13/2025
enCore Energy Corp. stock logo
EU
enCore Energy
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$2.75 ➝ $2.75
(Data available from 7/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
enCore Energy Corp. stock logo
EU
enCore Energy
$58.33M9.56N/AN/A$1.71 per share1.74
Fission Uranium Corp. stock logo
FCU
Fission Uranium
N/AN/AN/A17.71C$0.64 per shareN/A
IsoPlexis Co. stock logo
ISO
IsoPlexis
$16.76M1.81N/AN/A$1.04 per share0.73
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
enCore Energy Corp. stock logo
EU
enCore Energy
-$61.39M-$0.37N/A27.09N/A-142.32%-16.08%-13.96%N/A
Fission Uranium Corp. stock logo
FCU
Fission Uranium
-C$8.11M-C$0.01N/AN/AN/AN/A-1.69%-2.11%N/A
IsoPlexis Co. stock logo
ISO
IsoPlexis
-$106M-$2.70N/AN/AN/A-632.41%-127.86%-71.41%N/A

Latest BKY, ISO, FCU, and EU Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/12/2025Q1 2025
enCore Energy Corp. stock logo
EU
enCore Energy
-$0.02-$0.08-$0.06-$0.13$15.10 million$18.24 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
enCore Energy Corp. stock logo
EU
enCore Energy
N/AN/AN/AN/AN/A
Fission Uranium Corp. stock logo
FCU
Fission Uranium
N/AN/AN/AN/AN/A
IsoPlexis Co. stock logo
ISO
IsoPlexis
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
enCore Energy Corp. stock logo
EU
enCore Energy
N/A
2.94
2.61
Fission Uranium Corp. stock logo
FCU
Fission Uranium
0.05
23.97
20.34
IsoPlexis Co. stock logo
ISO
IsoPlexis
1.12
4.06
2.50

Institutional Ownership

CompanyInstitutional Ownership
enCore Energy Corp. stock logo
EU
enCore Energy
20.86%
Fission Uranium Corp. stock logo
FCU
Fission Uranium
18.87%
IsoPlexis Co. stock logo
ISO
IsoPlexis
44.91%

Insider Ownership

CompanyInsider Ownership
enCore Energy Corp. stock logo
EU
enCore Energy
N/A
Fission Uranium Corp. stock logo
FCU
Fission Uranium
11.90%
IsoPlexis Co. stock logo
ISO
IsoPlexis
6.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
enCore Energy Corp. stock logo
EU
enCore Energy
N/A187.06 millionN/AN/A
Fission Uranium Corp. stock logo
FCU
Fission Uranium
17858.74 millionN/ANot Optionable
IsoPlexis Co. stock logo
ISO
IsoPlexis
45939.76 million37.22 millionNot Optionable

Recent News About These Companies

Truecaller earns triple ISO certifications
Supplier Hub
How to buy the best conservatory furniture
Appointment supports accelerated growth in US OOC market
Global Single Cell Genomics Market Research Report…
Signal: Bruker continues acquisition spree with $108m PhenomeX purchase

New MarketBeat Followers Over Time

Media Sentiment Over Time

enCore Energy stock logo

enCore Energy NASDAQ:EU

$2.98 +0.01 (+0.34%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$3.00 +0.02 (+0.54%)
As of 07/18/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

enCore Energy Corp. engages in the acquisition, exploration, and development of uranium resource properties in the United States. It holds a 100% interest in Crownpoint and Hosta Butte uranium project area covers 3,020 acres located in the Grants Uranium Belt, New Mexico. The company also holds interest in the Marquez-Juan Tafoya property comprises 14,582 acres located in McKinley and Sandoval counties of New Mexico; and the Nose Rock project comprising 42 owned unpatented lode mining claims comprising approximately 800 acres located in McKinley County, New Mexico. In addition, it holds interest in the White Canyon District and Utah property package, including the Geitus, Blue Jay, Marcy Look, and Cedar Mountain projects located to the northwest of the White Mesa Mill at Blanding County, Utah. Further, the company holds a 100% interest in Dewey Burdock project comprises approximately 12,613 surface acres and 16,962 net mineral acres located in South Dakota; Gas Hills project consists of approximately 1,280 surface acres and 12,960 net mineral acres of unpatented lode mining claims located in Wyoming; and West Largo project consist of approximately 3,840 acres located in McKinley County, New Mexico. Additionally, it holds a 100% interest in Ambrosia Lake - Treeline property consists of deeded mineral rights totaling 24,555 acres and unpatented mining claims covering approximately 1,700 acres; and Checkerboard mineral rights covering a land position of approximately 300,000 acres located in the Grants Uranium District. The company was formerly known as Wolfpack Gold Corp. and changed its name to enCore Energy Corp. in August 2014. enCore Energy Corp. is headquartered in Corpus Christi, Texas.

Fission Uranium stock logo

Fission Uranium TSE:FCU

Fission Uranium Corp. engages in the acquisition, exploration, and development of uranium resource properties in Canada. Its flagship property is the 100% owned Patterson Lake South property with 17 contiguous mineral claims covering an area of 31,039 ha located in the Athabasca Basin region of Saskatchewan, Canada. The company was incorporated in 2013 and is headquartered in Kelowna, Canada.

IsoPlexis stock logo

IsoPlexis NASDAQ:ISO

IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.